Join today and have your say! It’s FREE!

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Please Try Again
{{ error }}
By providing my email, I consent to receiving investment related electronic messages from Stockhouse.

or

Sign In

Please Try Again
{{ error }}
Password Hint : {{passwordHint}}
Forgot Password?

or

Please Try Again {{ error }}

Send my password

SUCCESS
An email was sent with password retrieval instructions. Please go to the link in the email message to retrieve your password.

Become a member today, It's free!

We will not release or resell your information to third parties without your permission.
Quote  |  Bullboard  |  News  |  Opinion  |  Profile  |  Peers  |  Filings  |  Financials  |  Options  |  Price History  |  Ratios  |  Ownership  |  Insiders  |  Valuation

Bullboard - Stock Discussion Forum StageZero Life Sciences Ltd T.SZLS

Alternate Symbol(s):  SZLSF

StageZero Life Sciences, Ltd. is a Canada-based vertically integrated healthcare company. The Company is focused on improving the early detection and management of cancer and other chronic diseases through diagnostics telehealth programs. Its lead product, Aristotle, is a mRNA multi-cancer panel for simultaneously screening for multiple cancers from a single sample of blood with high... see more

TSX:SZLS - Post Discussion

StageZero Life Sciences Ltd > Whatever you do
View:
Post by Skrit37 on Jun 03, 2021 10:11am

Whatever you do

Make sure you vote....wether you see bright skies ahead ...or a hurricane.....vote ..vote ..vote.... Insiders hold +/- 10%.....retail has all of influence.... Vote darnit! Goodluck folks
Comment by molotov420 on Jun 03, 2021 10:14am
yep, sound advice skrit! and vote against lol
Comment by Mermer2328 on Jun 03, 2021 10:20am
all over it!!
Comment by Mermer2328 on Jun 03, 2021 10:21am
what a difference 2 months makes. Expecting big golden goose Aristotle rollout... yet jus crickets...
Comment by johnny007 on Jun 03, 2021 10:35am
Aristotle is now valued as if not existent. Good for us here. Aristotle rollout plan is delayed by roughly 6 month only, compared to Clarus earlier plan and unlike Clarus new negativity of 2 years. Good for us here. Let's celebrate the upcoming Aristotle paper and SHIFT product advertisements. C$32M MCAP is 1/10 of what still super cheap stocks in this sector are traded for ;-)
Comment by Zedd3333 on Jun 03, 2021 10:52am
This post has been removed in accordance with Community Policy
Comment by Zedd3333 on Jun 03, 2021 10:56am
This post has been removed in accordance with Community Policy
Comment by jjonahs on Jun 03, 2021 11:14am
I totally agree. Tripp can't be at the helm any longer. He's costing this company a fortune and he's not delivering on his promises. He needs to step down ...
Comment by Zedd3333 on Jun 03, 2021 12:05pm
This post has been removed in accordance with Community Policy
Comment by davewho on Jun 03, 2021 12:41pm
read the voting form. You are voting for company directors not the CEO. Shareholders have NO vote for the CEO. The only reason James name is there on the form is because he is a director and Chairman of the board. You can vote yes or withhold for James as director and Chairman ONLY. He will still be the CEO regardless until such time as he volunteers to step down or the BOD's ask him to step ...more  
Comment by Mermer2328 on Jun 03, 2021 12:50pm
Agreed, but a 50%+ withhold vote shows deteriorating confidence, which will have to be addressed. End of the day, its about making money
Comment by Melray on Jun 03, 2021 1:00pm
recieved my first of 4 voting packages. Already withheld all and rejected consolidation. A strong statement from investors to send message of dissatisfaction with the board. The boys need to get their shite together!
Comment by davewho on Jun 03, 2021 1:14pm
personally I don't think it will happen. Some posters are actively trying to de-stablize the company at the most crucial time in the company's history. They want to see James go, the s/p to fall and the Care deal to collapse. Result? SZLS would be left in disarray with no way to market Aristotle and save lives. Now who would that be? Likely bigger fish here than the usual basement bash ...more  
Comment by Melray on Jun 03, 2021 1:07pm
if the present szls Board implementation of Aristotle doesn't achieve results as anticipated. We need to nominate alternative directors to be elected at annual stockholders meeting! I'll request Corporate bylaws from IR and share process.
Comment by johnny007 on Jun 03, 2021 12:51pm
Hi Zed. CEO has always answered my questions directly, just for the record. And this, despite my not so elegant tone ;-) Will SZLS turnaround? Sure, it always does. Only the 'end of the world is neigh' tone brings down this ship, as usual. The valuation is far too low, we all know that. This regardless of the 'clumsy' actions of company. Yes yes, I elaborated on this a ...more  
The Market Update
{{currentVideo.title}} {{currentVideo.relativeTime}}
< Previous bulletin
Next bulletin >

At the Bell logo
A daily snapshot of everything
from market open to close.

{{currentVideo.companyName}}
{{currentVideo.intervieweeName}}{{currentVideo.intervieweeTitle}}
< Previous
Next >
Dealroom for high-potential pre-IPO opportunities